Mykhailo Mudryk Cleared to Play Again for Chelsea

Mykhailo Mudryk has been cleared to play again, ending a long and bruising spell on the sidelines that threatened to define his Chelsea career before it had truly begun.

The 25-year-old winger has not featured in a competitive match since November 2024, after being hit with a four-year suspension for a failed drugs test that dated back two years. That test showed a low concentration of meldonium, a substance on the World Anti-Doping Agency’s prohibited list at the time.

Now, the landscape has shifted.

A Ban Overtaken by Science

Mudryk took his case to the Court of Arbitration for Sport, contesting the severity of the punishment. While the legal wheels turned, the science moved faster.

Changes to World Anti-Doping Agency procedures and reporting standards mean that, if the same sample were taken and analysed today, it would not trigger a charge at all. The Football Association laid that out in stark terms.

“Changes have been made… which, while not retroactive, mean that if Mr Mudryk's sample was collected today, the concentration of meldonium in the sample would not have been reported and no anti-doping rule violations would have resulted,” the FA said.

That shift proved decisive. With WADA’s agreement, the FA and Mudryk have now resolved the appeal.

As part of the settlement, Mudryk accepted that he had committed the Anti-Doping Rule Violations originally charged and agreed to a period of ineligibility equal to the time he has already served. The punishment stands on paper. In practical terms, it ends here.

“Mr Mudryk is no longer ineligible and may return to competition with immediate effect,” the FA confirmed.

Chelsea Get Their £88m Winger Back

For Chelsea, this is more than a legal footnote. It is the restoration of a major investment.

The Blues paid £88m to prise Mudryk from Shakhtar Donetsk in January 2023, a deal that was supposed to bring one of Europe’s most explosive wide forwards to the Premier League for his peak years. Instead, his momentum stalled just as he was trying to settle into English football.

Chelsea’s reaction to the resolution carried a clear sense of relief and a pointed emphasis on the updated science.

“We welcome the acknowledgement that advances in the applicable scientific reporting standards for more reliable testing mean that, had Misha's sample been analysed under today's technical requirements, it would not have been reported as a positive test and no anti-doping rule violation would have resulted,” the club said.

“That is an important part of the context surrounding the agreed resolution and allows everyone involved to move forward.”

The message is obvious: the player’s name, and by extension the club’s judgement, sits in a very different light under current rules.

A Career Reboot

Mudryk’s return does not erase the missed months, the scrutiny, or the stigma that attaches to any doping case, however nuanced. He remains a player who has served a ban and accepted rule violations, even as the governing bodies acknowledge that modern standards would not have flagged his test.

What it does offer is a clean competitive slate.

Chelsea, juggling a heavy schedule and still trying to mould a coherent attacking unit, suddenly have back a winger with pace, directness and the ability to stretch defences. For a squad that has lurched between rebuild and reset, the timing could be significant.

Mudryk, once the symbol of a bold recruitment drive, now returns with something else: a second chance to prove he belongs at the sharp end of the Premier League, under rules that have finally caught up with his case.